BioAxone is making great strides in developing products that will make a difference and change the world.
Research driven medical solutions is what we strive for. Our goal is changing lives in a healthier way.
Learn more about our company.
Since its inception, Bioaxone has been focused on the use of Rho GTPase signalling. This pathway contains a broad array of proteins, making it ideal for research. We have developed a C3 exoenzyme-based Rho inhibitor by re-engineering the C3 exoenzyme, changing its size and adding a transport motif. Early patenting of these medical discoveries has given us the freedom to conduct clinical trials.
Innovation is what we do.
Research-driven medical solutions
Sustainability is Key